Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Molecular Sciences|September 10, 2021
Copper Oxide Nanoparticle-Induced Acute Inflammatory Response and Injury in Murine Lung Is Ameliorated by Synthetic Secoisolariciresinol Diglucoside (LGM2605)Ralph A Pietrofesa, Kyewon Park, Om P Mishra, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapyBrian C Baumann, Thomas J Guzzo, Jiwei He, et al.
Translational Oncology|June 22, 2010
The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot StudySydney M Evans, Kevin W Jenkins, H Isaac Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patientsJeffrey C Thompson, Ryan Fan, Taylor Black, et al.
JCO Precision Oncology|August 21, 2019
Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung CancerErin Bange, Melina E Marmarelis, Wei-Ting Hwang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2017
Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology PatientsKatherine T Marcucci, Julie K Jadlowsky, Wei-Ting Hwang, et al.
Cytotherapy|November 3, 2018
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomasNirav N Shah, Sarah J Nagle, Drew A Torigian, et al.
Pulmonary Circulation|December 7, 2020
Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertensionPriyanka T Bhattacharya, Asif M Abdul Hameed, Shubhadeep T Bhattacharya, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaAndrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
The Journal of Investigative Dermatology|October 26, 2013
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathwayTao Wang, Yingbin Ge, Min Xiao, et al.
Pageof 24